| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4381 nt | 0.3559 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4288 nt | 0.3547 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4261 nt | 0.3551 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4364 nt | 0.3533 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4446 nt | 0.3572 | |
| CCCUUUCUCCAGGCUCCCCGCCACCGGAGGGAGAGAGGGAGGACCCGUC… | 4250 nt | 0.3466 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4404 nt | 0.3554 | |
| AUAUUGUCGCUAGUGGCCGCUGGGGCUGGGAGGGGUGUGCUAGAGAGGC… | 4408 nt | 0.3555 |
The protein encoded by this gene has ubiquitin ligase activity. It mediates E3-dependent ubiquitination and proteasomal degradation of target proteins, including tumor protein 53, histone deacetylase 1, and cyclin-dependent kinase inhibitor 1B, thus regulating their levels and cell cycle progression. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2013]
A study in mice demonstrated that chronic methamphetamine administration significantly dysregulated the RCHY1 in cortical microglia, as part of widespread alterations in the ubiquitin-mediated proteolysis pathway [Oladapo et al. DOI:10.3390/Ijms26020649].